| 摘要 |
The present invention relates to a combination of (a) a glutamate neurotransmission modulating compound or a pharmaceutically acceptable salt thereof and (b) a serotonin reuptake inhibitor or a serotonin-1A (5HT1A) receptor ligand, or a pharmaceutically acceptable salt of such inhibitor or ligand and the uses of such a ligand.
|
